Craneware says US healthcare market evolving as interim profit surges
Craneware PLC on Monday said it has ‘never been more confident in the vital role we play’ in helping its customers handle changes to the US healthcare market.
It also announced a higher interim dividend, as half-year revenue climbed sharply.
The Edinburgh-based software solutions provider said pretax profit jumped 29% to $13.0 million in the six months to December 31, from $10.1 million a year ago. Revenue climbed 5.7% to $105.7 million from $100.0 million.
Craneware announced an interim dividend of 15.0 pence per share, up 11% from 13.5p a year ago.
Looking ahead, Craneware highlighted ‘innovation’ to ‘profoundly’ impact US healthcare operations, which will drive demand and expand the firm’s addressable market.
Further, it said it sees its Microsoft Corp partnership as ‘proving major benefits to our customers, Craneware and Microsoft.’
Chief Executive Officer Keith Neilson said: ‘The US healthcare market continues to evolve at pace, and with each new piece of legislation or change, the need for data-led insights and a secure and scalable technology partner grows. We have never been more confident in the vital role we play in enabling our customers to navigate these changes with confidence, while maintaining their financial strength and delivery of care. This is a hugely powerful motivator for all of us at The Craneware Group.
‘With our wealth of proprietary data, deep industry expertise, longstanding and extensive customer base, and growing AI capabilities, the board looks to the future with confidence.’
Craneware shares were 0.6% higher at 1,524.09 pence each on Monday afternoon in London.
Copyright 2026 Alliance News Ltd. All Rights Reserved.